Debiopharm Innovation Fund looking for patient care startups
Posted on 20.02.2017 in News
20.02.2017 Formerly known as Debiopharm Diagnostics, Debiopharm Innovation Fund has become the strategic investment fund of the Group based in Lausanne. It focuses its investments in young innovative companies and startups with opportunities in Patient Care.
As seen it its latest newsletter, Debiopharm has made important changes in its investment strategy. In the past the group has invested in startups such as Coorpacademy or Skiioo in Western Switzerland via its Debiopharm Investment company. Today this team is fully dedicated to support the sustainable growth of the Group and focuses its investment efforts in more mature ventures. Startups with investment opportunities in patient care must turn today to the Debiopharm Innovation Fund, the strategic investment fund of the Debiopharm Group which invests in three specific areas:
- Smart data (pilot or early commercial stage),
- Therapeutics (discovery and early development)
- Diagnostics (development stage).